Unlocking
Precision Biomarkers
for Neurology

Objective, accurate biomarkers of brain function, built on decades of research and powered by AI.

TECHNOLOGY

The Future of Brain Function Measurement

Our platform employs advanced computer vision models and machine learning algorithms to precisely capture and analyze dozens of oculometric measures. These measures are then translated into clinical insights, providing comprehensive information on various aspects of patients' conditions.

Learn More

Publications

Parkinsonism & Related Disorders

Monitoring Parkinson’s Progression: Eye Movements vs. MDS-UPDRS III

2025
Neurology

Correlations between traditional disability assessment and oculometric measures in Multiple Sclerosis

2024
Frontiers in Digital Health

Advancements in eye movement measurement technologies for assessing neurodegenerative diseases

2024
Applied science

Video-based gaze detection for oculomotor abnormality measurements

2024
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Changes in saccadic intrusions over time as an objective biomarker to follow ALS disease progression

2024
Journal of Neural Transmission

Oculometric measures as a tool for assessment of clinical symptoms and severity of Parkinson’s disease

2023
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial

2023
Acta Ophthalmologica (Copenhagen)

Validation of a novel software-based platform to extract oculometric measures

2022

Clinical Partnerships

NeuraLight is a part of multiple clinical partnerships for different CNS diseases conducted in leading medical centers worldwide.

Learn More
Partnerships

Learn how precision biomarkers are revolutionizing neurology

Contact Us